WuXi AppTech IPO Update: Figuring Out the Right AH Premium
WuXi AppTec Co. Ltd. (WUXI HK) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....
716 Views
Ascletis Pharma IPO Preview: Drug-Fuelled Euphoria Needed to Justify Valuation
Ascletis Pharma Inc (AP HK) which specialises in developing drugs to treat HCV (hepatitis C virus), HIV and liver cancer, is the first pre-profit...
745 Views
Legend's Conversion of Domestic Shares
Yesterday, a CCASS filing highlighted 850mn shares entering Legend Holdings Corp H (3396 HK)'s share registry via CCASS Participant ID A00002, as...
317 Views
Quiddity Weekly H/A: Discounts & Southbound Flows 20180126
This is a new H/A Spread monitor project offering a brief look at recent changes in H-Share and A-Share spreads, Southbound flow and impact, and...
366 Views
Inventory Growth > COGS Growth for 4 Years Now for Livzon Pharm
Joincare (600380.CH) is a controlling shareholder of Livzon and also is the top supplier for Livzon. What does it do to the inventory growth in...
314 Views